Company Profile
Autolus Therapeutics plc Stock Price, News & Analysis
- Ticker:
- AUTL
- Exchange:
- NASDAQ
- Sector:
- Biotechnology
- Location:
- Headquartered in the United States and listed on NASDAQ, Autolus Therapeutics plc is followed within the biopharmaceutical universe for its exposure to pipeline and commercialization catalysts.
Stock performance
1.66 USD (+11.41%)
Close
Last updated: June 23, 2026 at 00:00
441.8M USD
Market cap
Why the stock is moving
AUTL is trading with a steady catalyst profile while investors wait for the next headline that changes the story.
Company overview
Business overview
Autolus Therapeutics plc is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
Geographic Base and Sector Classification
Headquartered in the United States and listed on NASDAQ, Autolus Therapeutics plc is followed within the biopharmaceutical universe for its exposure to pipeline and commercialization catalysts.
Business Model Characteristics
Autolus Therapeutics plc follows a pipeline-led model where clinical readouts, filing updates, and program expansion determine how the market underwrites the story.
Position Within the Biotechnology Landscape
Compared with more mature healthcare names, Autolus Therapeutics plc sits on the development side of the biotech landscape, where catalyst timing can reprice the stock quickly.
Future catalysts
Recent news
The five most recent feed items are shown below in reverse chronological order.
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of Autolus Therapeutics plc (AUTL)?
Autolus Therapeutics plc (AUTL) most recently closed at 1.66 USD, a +11.41% move versus the previous session.
What is the market cap of Autolus Therapeutics plc (AUTL)?
Autolus Therapeutics plc currently has a market capitalization of 441.8M USD on BioPharmSignal.
What does Autolus Therapeutics plc do?
Autolus Therapeutics plc is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
On which exchange is AUTL stock listed?
Autolus Therapeutics plc (AUTL) is associated with NASDAQ, Headquartered in the United States and listed on NASDAQ, Autolus Therapeutics plc is followed within the biopharmaceutical universe for its exposure to pipeline and commercialization catalysts., Biotechnology.
What is Autolus?
Autolus Therapeutics plc is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
Which conditions is Autolus Therapeutics plc targeting with Autolus?
Autolus Therapeutics plc is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
What is Therapeutics?
Autolus Therapeutics plc is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.